Inhibitors for the Glutamine Transporter ASCT2
A portfolio of novel glutamine transporter ASCT2 inhibitors with affinities in the lower micromolar down to the nanomolar range.
Background:
Changes in cell metabolism support rapid growth and proliferation of tumor cells, resulting in increased reliance on the metabolism of amino acids such as glutamine (i.e., ‘glutamine addiction’)....
Published: 12/28/2023
|
Inventor(s): Christof Grewer, Elias Ndaru, Yueyue Shi, Laura Zielewicz
Keywords(s): #SUNYresearch, Technologies
Category(s): Campus > Binghamton University, Technology Classifications > Therapeutics and Vaccines
|